Induction Healthcare Group PLC (AIM: INHC)
London
· Delayed Price · Currency is GBP · Price in GBX9.00
-0.50 (-5.26%)
Nov 15, 2024, 2:13 PM GMT+1
INHC Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Revenue | 12.78 | 13.65 | 12.88 | 7.23 | 1.36 | 0.15 | Upgrade
|
| Revenue Growth (YoY) | 3.45% | 5.93% | 78.18% | 431.30% | 819.59% | - | Upgrade
|
| Cost of Revenue | 2.57 | 2.95 | 4.75 | 2.75 | 0.64 | 0.07 | Upgrade
|
| Gross Profit | 10.21 | 10.7 | 8.13 | 4.48 | 0.73 | 0.08 | Upgrade
|
| Selling, General & Admin | 6.69 | 6.11 | 8.47 | 7.93 | 5.12 | 2.6 | Upgrade
|
| Research & Development | 8.54 | 8.79 | 9.29 | 5.26 | 1.89 | 0.96 | Upgrade
|
| Operating Expenses | 15.23 | 14.9 | 17.75 | 13.19 | 7.01 | 3.57 | Upgrade
|
| Operating Income | -5.02 | -4.2 | -9.62 | -8.71 | -6.28 | -3.49 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | - | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0 | 0 | 0 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | - | - | -0 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.94 | -4.21 | -9.63 | -8.74 | -6.29 | -3.44 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.42 | -0.38 | - | Upgrade
|
| Impairment of Goodwill | - | - | -7.76 | - | -0.42 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.95 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.09 | -0.08 | Upgrade
|
| Pretax Income | -4.94 | -4.21 | -17.39 | -9.16 | -8.12 | -3.53 | Upgrade
|
| Income Tax Expense | -1.49 | -0.96 | -0.8 | -1.08 | -0.5 | - | Upgrade
|
| Earnings From Continuing Operations | -3.45 | -3.25 | -16.59 | -8.08 | -7.61 | -3.53 | Upgrade
|
| Earnings From Discontinued Operations | -0.47 | -0.01 | -0.8 | -0.36 | - | - | Upgrade
|
| Net Income | -3.92 | -3.26 | -17.38 | -8.43 | -7.61 | -3.53 | Upgrade
|
| Net Income to Common | -3.92 | -3.26 | -17.38 | -8.43 | -7.61 | -3.53 | Upgrade
|
| Shares Outstanding (Basic) | 94 | 93 | 92 | 82 | 40 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 93 | 92 | 82 | 40 | 26 | Upgrade
|
| Shares Change (YoY) | 1.19% | 0.45% | 12.02% | 107.70% | 51.60% | 98.97% | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.19 | -0.10 | -0.19 | -0.13 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.19 | -0.10 | -0.19 | -0.13 | Upgrade
|
| Free Cash Flow | -0.24 | -1.09 | -2.83 | -2.32 | -4.02 | -3.35 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.03 | -0.03 | -0.10 | -0.13 | Upgrade
|
| Gross Margin | 79.92% | 78.40% | 63.10% | 61.96% | 53.27% | 50.68% | Upgrade
|
| Operating Margin | -39.26% | -30.79% | -74.68% | -120.38% | -461.65% | -2358.78% | Upgrade
|
| Profit Margin | -30.69% | -23.86% | -134.92% | -116.61% | -559.44% | -2383.11% | Upgrade
|
| Free Cash Flow Margin | -1.87% | -7.96% | -21.93% | -32.04% | -295.15% | -2260.81% | Upgrade
|
| EBITDA | -3.47 | -2.78 | -7.82 | -7.55 | -6.03 | -3.42 | Upgrade
|
| EBITDA Margin | -27.14% | -20.35% | -60.70% | -104.41% | - | - | Upgrade
|
| D&A For EBITDA | 1.55 | 1.43 | 1.8 | 1.16 | 0.26 | 0.07 | Upgrade
|
| EBIT | -5.02 | -4.2 | -9.62 | -8.71 | -6.28 | -3.49 | Upgrade
|
| EBIT Margin | -39.26% | -30.79% | -74.68% | -120.38% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.